https://www.frontiersin.org/journals/surgery RSS Feed for Frontiers in Surgery | New and Recent Articles en-us Frontiers Feed Generator,version:1 2026-08-18T03:28:35.759+00:00 60 https://www.frontiersin.org/articles/10.3389/fsurg.2026.1860573 https://www.frontiersin.org/articles/10.3389/fsurg.2026.1860573 2026-08-17T00:00:00Z Original Research Run ZhangQiongfang ZhangXiaolan ZhaoYu ZhouMengjie CaiNa YinPan XieYi WuLihua Fu https://www.frontiersin.org/articles/10.3389/fsurg.2026.1845405 https://www.frontiersin.org/articles/10.3389/fsurg.2026.1845405 2026-08-17T00:00:00Z Original Research Akay EdizsoyOrkhan MirzayevHatice Barakİbrahim MeteoğluPars Tunçyürek https://www.frontiersin.org/articles/10.3389/fsurg.2026.1844626 https://www.frontiersin.org/articles/10.3389/fsurg.2026.1844626 2026-08-17T00:00:00Z Original Research Jie MaHengjun Wang https://www.frontiersin.org/articles/10.3389/fsurg.2026.1818308 https://www.frontiersin.org/articles/10.3389/fsurg.2026.1818308 2026-08-17T00:00:00Z Original Research David MamanYaniv SteinfeldYaron Berkovich https://www.frontiersin.org/articles/10.3389/fsurg.2026.1881730 https://www.frontiersin.org/articles/10.3389/fsurg.2026.1881730 2026-08-17T00:00:00Z Original Research Barbara De AngelisDavide Johan BottiniChiara Di SegniLorenzo SecondiMarco GerardiMargarida Fernandes Lopes Morais D’AutilioNico PreiteAlfredo PisapiaPietro GentileDario CrocoliDaniele Di GiovanniMariachiara CarestiaLeonardo PalombiFabrizio OrlandiValerio Cervelli https://www.frontiersin.org/articles/10.3389/fsurg.2026.1884577 https://www.frontiersin.org/articles/10.3389/fsurg.2026.1884577 2026-08-17T00:00:00Z Case Report Junting GuanJiyuan ChenShengqi PanQi LiGuiyu WangQingchao Tang https://www.frontiersin.org/articles/10.3389/fsurg.2026.1875200 https://www.frontiersin.org/articles/10.3389/fsurg.2026.1875200 2026-08-17T00:00:00Z Original Research Chen LiuJiali ZhangLiu YangLifang Tan https://www.frontiersin.org/articles/10.3389/fsurg.2026.1848812 https://www.frontiersin.org/articles/10.3389/fsurg.2026.1848812 2026-08-14T00:00:00Z Case Report Matthew GaynorMahmoud MorsiJavier GonzalezOmaida VelazquezHenry Ocando NavaGaetano Ciancio https://www.frontiersin.org/articles/10.3389/fsurg.2026.1887903 https://www.frontiersin.org/articles/10.3389/fsurg.2026.1887903 2026-08-14T00:00:00Z Case Report A. V. ShabuninM. G. MininaP. A. DrozdovO. N. LevinaS. A. AstapovichD. A. MakeevD. A. SolomatinI. I. KurbanovA. I. Yurik https://www.frontiersin.org/articles/10.3389/fsurg.2026.1923049 https://www.frontiersin.org/articles/10.3389/fsurg.2026.1923049 2026-08-13T00:00:00Z Case Report Ke YangPing LiXuan Long https://www.frontiersin.org/articles/10.3389/fsurg.2026.1814943 https://www.frontiersin.org/articles/10.3389/fsurg.2026.1814943 2026-08-13T00:00:00Z Original Research Vincent G. J. GuillaumeRon MartinJonas RoosRobert KaczmarczykJustus P. BeierBenedikt SchäferTim Leypold https://www.frontiersin.org/articles/10.3389/fsurg.2026.1936791 https://www.frontiersin.org/articles/10.3389/fsurg.2026.1936791 2026-08-13T00:00:00Z Case Report Xavier Wong-AchiAmbar Riley-MoguelJosé Guillermo Flores-VázquezAlejandro Becerril-MejíaDora Yvette Lugo-HilarioEdgar Nathal https://www.frontiersin.org/articles/10.3389/fsurg.2026.1890509 https://www.frontiersin.org/articles/10.3389/fsurg.2026.1890509 2026-08-13T00:00:00Z Case Report Emma Bonetti PalermoMichela ZorziFederica PozzatiFederico FerrariFranco OdicinoAntonia Carla TestaUrsula Catena https://www.frontiersin.org/articles/10.3389/fsurg.2026.1862072 https://www.frontiersin.org/articles/10.3389/fsurg.2026.1862072 2026-08-13T00:00:00Z Original Research Xinming YangYakun DuYe TianYao YaoLixing ChenNingKui Niu  0.05); supplementary stratified comparison of abscess size, vertebral destruction severity and spinal canal occupation ratio between groups was performed to further verify intergroup clinical comparability, indicating good comparability. The minimally invasive group was significantly superior to the open group in perioperative indicators including operation time, intraoperative blood loss, surgical incision length, postoperative bed rest time, and hospital stay (P < 0.05), with medium-to-large effect sizes confirming clinical meaningful gaps. At 1 week, 1 month, 3 months, 6 months, and 12 months postoperatively, the reductions in VAS score, ODI, ESR, and CRP in the minimally invasive group were significantly greater than those in the open group (P < 0.05), and MCID thresholds were reached in most time points, representing clinically meaningful pain relief and inflammatory improvement. The excellent and good rate of neurological function recovery was 90.9% in the minimally invasive group and 75.0% in the open group, with no significant difference between the two groups (P > 0.05). The bone fusion rate was 92.1% in the minimally invasive group and 88.2% in the open group, showing comparable spinal fusion effects (P > 0.05). The postoperative complication rate was 21.05% in the minimally invasive group, significantly lower than 76.47% in the open group (P < 0.05), with large effect size supporting clinical safety advantages. At 12-month follow-up, the disease recurrence rate was 2.6% in the minimally invasive group and 8.8% in the open group, with no significant difference between the two groups (P > 0.05).ConclusionMinimally invasive spine surgery techniques are safe and feasible in the treatment of Type Ⅱ/Ⅲ BS, achieving thorough debridement, reliable infection control reflected by reduced inflammatory markers, and sufficient nerve decompression. They are comparable to conventional open surgery in neurological recovery, clinical efficacy and spinal fusion outcomes, while possessing significant perioperative advantages such as less surgical trauma, less intraoperative bleeding, faster postoperative recovery, and lower complication rate. Considering the retrospective design, mixed minimally invasive intervention heterogeneity and lack of long-term follow-up beyond 12 months, minimally invasive techniques may serve as a preferred alternative surgical option for appropriately selected Type Ⅱ/Ⅲ BS patients who meet strict minimally invasive surgical indications, rather than a universal first-line scheme for all Type Ⅱ/Ⅲ BS cases.]]> https://www.frontiersin.org/articles/10.3389/fsurg.2026.1906216 https://www.frontiersin.org/articles/10.3389/fsurg.2026.1906216 2026-08-12T00:00:00Z Original Research Khang Duy Ricky LeKevin Kah Wai YoongLeon YeungIman HameedNicholas AngDavid Patrick HeathDavid LloydMinh Hung Nguyen https://www.frontiersin.org/articles/10.3389/fsurg.2026.1880320 https://www.frontiersin.org/articles/10.3389/fsurg.2026.1880320 2026-08-12T00:00:00Z Case Report Zdravka HarizanovaFerihan Ahmed-PopovaVasil PavlovElena Bozhikova https://www.frontiersin.org/articles/10.3389/fsurg.2026.1915384 https://www.frontiersin.org/articles/10.3389/fsurg.2026.1915384 2026-08-12T00:00:00Z Original Research Çağla ÇiçekSamed O. AkınCem AydınGaye Filinte https://www.frontiersin.org/articles/10.3389/fsurg.2026.1889766 https://www.frontiersin.org/articles/10.3389/fsurg.2026.1889766 2026-08-12T00:00:00Z Case Report Zhenyu ZhangHuiling WangYaqin WuYali LeiChaojie Zhang https://www.frontiersin.org/articles/10.3389/fsurg.2026.1855285 https://www.frontiersin.org/articles/10.3389/fsurg.2026.1855285 2026-08-12T00:00:00Z Original Research Hang YuJianJun WuXiuLin WangJiaHao LuoWeiLong DuYuXue LuoZhongPing XuYunBing WangXiong Ding  0.05). CA19-9 (OR:0.999,P=0.027) was a protective factor for POPF. SMI (OR: 1.165, P = 0.041), neutrophils (OR: 1.191, P = 0.005), and Operative blood loss (OR: 1.001, P = 0.022) were independent risk factors for 30-day readmission. Multivariable analysis identified sarcopenia (HR=1.935,P=0.012) as an independent predictor of OS. Based on ROC curve analysis, the optimal cutoff values for NLR and CAR were exploratorily identified as 2.705 and 0.372. Survival analysis revealed that patients with sarcopenia combined with either high NLR (>2.705) or high CAR (>0.372) had significantly shorter mean OS compared to non-sarcopenic patients with low NLR or low CAR (P=0.007,P=0.001). Specifically, the concurrent presence of sarcopenia and high NLR was associated with the highest mortality risk (HR=5.155,P=0.007), followed by the combination of sarcopenia and high CAR (HR=2.808,P=0.001).ConclusionPreoperative sarcopenia is an independent predictor of poor OS following PD. The coexistence of sarcopenia and a high inflammatory state (i.e., high NLR or high CAR) significantly increases the risk of mortality. Therefore, preoperative assessment of skeletal muscle mass and inflammatory status may be crucial for identifying high-risk patients.]]> https://www.frontiersin.org/articles/10.3389/fsurg.2026.1901971 https://www.frontiersin.org/articles/10.3389/fsurg.2026.1901971 2026-08-12T00:00:00Z Original Research Ilkhom B. KhayitovAkhmadjon B. BabajonovSaidislomxon S. Sayidburxonov